FDA Panel Urges Limits On Sanofi-Aventis (France) Antibiotic
SILVER SPRING, Md., Dec 15 (Reuters) - Sanofi-Aventis antibiotic Ketek should stay on the market but use should be limited to treating pneumonia, U.S. advisers said on Friday after reviewing rare cases of liver failure and other problems.